Drugs / Fluarix/Influsplit Tetra®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01878812 | Jul → Aug 2013 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluarix/Influsplit Tetra | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01878812 ↗ |
| Modality | Vaccine | “Quadrivalent Influenza Vaccine” NCT01878812 ↗ |
| Route | Intramuscular | “administered intramuscularly in the deltoid region of non-dominant arm” NCT01878812 ↗ |